Nano-enhanced tobramycin treats severe lung infections with only 2 doses
Phys.org - 13-May-2021Antibiotic's efficacy improved by 100,000 times in treating cystic fibrosis - currently in preclinical stage
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Pharmacist, PhD student at the University of South Australia
Chelsea Thorn is a PhD student at the University of South Australia and is also a visiting PhD researcher at Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). She holds a Bachelor of Pharmacy (Hons) from the University of South Australia and is currently an Australian registered Pharmacist. Her research focus is based around improving the delivery of antimicrobial bio-macromolecules to treat biofilm-related infections.
Visit website: https://unisa-au.academia.edu/ChelseaThorn
See alsoDetails last updated 23-May-2021
Antibiotic's efficacy improved by 100,000 times in treating cystic fibrosis - currently in preclinical stage